Blog / Archives
Large Cap Biopharmaceuticals: Performance and Metric Update Part I
Large Cap Biopharmaceuticals 2018 Performance after J.P.Morgan Healthcare Conference Here is an update of Large Cap Biopharmaceuticals Performance over the past 12 months. These numbers will be...
2018 J.P.Morgan Healthcare Conference #5: Companies to Watch
J.Morgan Healthcare Conference: Companies to Watch We are still reviewing 2018 J.P.Morgan Healthcare presentations for inclusion in our portfolio but here are two longer term opportunities to track...
2018 J.P.Morgan Healthcare Conference #4 Notes from Panel: Key Trends in Diagnostics and Lifesciences
Key Trends in Diagnostics and Lifesciences: Promise, Reality Reimbursement Panel Moderator: Ken Bahk, Three Lake Partners. Panelists- Nathan Ledeboer, Medical College of Wisconsin,Victoria Pratt,...
2018 J.P.Morgan Healthcare Conference #3: ABBV and BMY…Update
Sluggish Early Trading in Biotech Tracks NASDAQ Down 0.14%% Promising Year for M&A and Tax Cuts Improving Bottom Line There is a little follow-on to Tuesday's rally bringing prices for major...
2018 J.P.Morgan Healthcare Conference #2: Digital Health Session Notes
2018 Digital Health Panel: Is Digital Health at an Inflection Point? A packed session in the Colonial Room at the J.P.Morgan Healthcare Conference heard a panel of scientists, investors and...
2018 J.P.Morgan Healthcare Conference Day One Notes: Weak Start Despite Positive Updates
Weak Start for Biotech Stocks on 1/8/18-Red Screen Day Positive Updates on BIIB CELG GILD etc Biotech ETFs Firm Up about 1.5% Tuesday AM JPMorgan Healthcare Conference Biotech stocks abruptly sold...
Biotech ETFs vs Active Funds: Fidelity Biotech Fund Outperforms the IBB…Update
Biotech ETF Performance Updates as of 4/11/18 YTD FBT First Trust NYSE Arca Biotech ETF is the leader in 2018. FBT up 7.45% Top Five Holdings are: AVXS, NKTR, XON, AGIO, TECH. The holdings are quite...
Rayno Biopharma Portfolio 2017 Summary Performance…Updates
2/28/18 Update Tape looks sluggish at major resistance. Downgrade to HOLD on Celgene (CELG). Bad regulatory news on relapsing multiple sclerosis drug ozanimod. 2/2/18 Update After Sell-Off Cautious...
Biotech Bounce “Ignyted” By Roche Deal
Biotech Bounce Ignited By Roche (RHHBY) Buy of Ignyta (RXDX) NASDAQ Flat at 6953 Healthcare sector weak down 0.43%. as of 1 PM EST Trading Biotech stocks escaped the doldrums today ignited by Roche...
What’s Up With Diagnostics and Tools Stocks? Big Winners Are In Personalized Medicine- FMI, ILMN
Clinical Diagnostics and Tools: Big Winners Are In Genomics and Personalized Medicine Slower growth in routine clinical diagnostics, tools are favored. Hologic has a unique business model for...